developsTreatmentFor

P69333
predicate

Indicates that one entity creates or advances a medical or therapeutic intervention intended to address a condition, disease, or problem affecting another entity.

Observed surface forms (3)

Surface form Occurrences
developedForTreatmentOf 1
treatmentDevelopedClass 1
treatmentDevelopedIs 1

Sample triples (30)

Subject Object
Regeneron Pharmaceuticals age-related macular degeneration
Regeneron Pharmaceuticals diabetic macular edema
Regeneron Pharmaceuticals atopic dermatitis
Regeneron Pharmaceuticals asthma
Regeneron Pharmaceuticals cancer
Regeneron Pharmaceuticals inflammatory diseases
Regeneron Pharmaceuticals COVID-19
Ridgeback Biotherapeutics Ebola virus disease NERFINISHED
Ridgeback Biotherapeutics COVID-19 NERFINISHED
Ridgeback Biotherapeutics serious infectious diseases
Alexion Pharmaceuticals paroxysmal nocturnal hemoglobinuria
Alexion Pharmaceuticals atypical hemolytic uremic syndrome
Alexion Pharmaceuticals generalized myasthenia gravis
Alexion Pharmaceuticals neuromyelitis optica spectrum disorder NERFINISHED
Alexion Pharmaceuticals hypophosphatasia
Alexion Pharmaceuticals lysosomal acid lipase deficiency
Genzyme Gaucher disease NERFINISHED
Genzyme Fabry disease
Genzyme Pompe disease NERFINISHED
Genzyme multiple sclerosis
Genzyme chronic kidney disease
BioMarin Pharmaceutical mucopolysaccharidosis I
BioMarin Pharmaceutical mucopolysaccharidosis VI
BioMarin Pharmaceutical mucopolysaccharidosis IVA NERFINISHED
BioMarin Pharmaceutical phenylketonuria
BioMarin Pharmaceutical CLN2 disease
BioMarin Pharmaceutical achondroplasia
Augusto Odone adrenoleukodystrophy via predicate surface "developedForTreatmentOf"
Augusto Odone mixture of oleic acid and erucic acid via predicate surface "treatmentDevelopedIs"
Augusto Odone dietary therapy via predicate surface "treatmentDevelopedClass"